Treatment of Premature Ejaculation in Diabetic Patients

Initial Assessment and Diagnostic Priorities

The American Urological Association recommends distinguishing premature ejaculation from erectile dysfunction through detailed sexual history, as these conditions frequently coexist and require different management approaches 2
If both premature ejaculation and erectile dysfunction are present, treat the erectile dysfunction first, as many patients with ED develop secondary PE due to anxiety or the need for intense stimulation to maintain erection 2, 3, 4
Key elements to assess in the sexual history include time to ejaculation, frequency and duration of PE, relationship to specific partners, degree of stimulus causing PE, impact on sexual activity and quality of life, and any aggravating factors 2

The American Urological Association recommends starting sertraline at 50 mg daily and titrating to 200 mg based on clinical response, as daily sertraline dosing is superior to on-demand use 1
Daily administration of sertraline produces substantially greater ejaculatory delay compared to situational dosing 1
On-demand sertraline (50 mg taken 4-8 hours before intercourse) is modestly efficacious but produces less ejaculatory delay than daily treatment 1

Topical lidocaine/prilocaine spray applied 20-30 minutes before intercourse increases ejaculatory latency up to 6.3-fold with minimal systemic effects 3, 4, 2
For partial responders to SSRIs, consider combining daily low-dose SSRI with on-demand dosing 3

Never abruptly discontinue daily SSRIs—always taper to prevent SSRI withdrawal syndrome 1, 3, 4
Screen for concurrent use of other serotonergic medications before prescribing to avoid serotonin syndrome 1, 3
Avoid sertraline in men with bipolar depression due to risk of triggering mania 1, 3

The efficacy of PE treatments in diabetic patients is independent of diabetes duration, glycemic control, and microvascular complications 5, 6
Initial management should still include counseling on risk factor reduction and glycemic optimization, even though no studies have shown that improved glycemic control directly improves PE 5, 6

Patient and partner satisfaction is the primary target outcome for PE treatment, not just ejaculatory latency improvement 2, 3
Discuss risks and benefits of all treatment options before initiating therapy, emphasizing that PE is not life-threatening and safety should be a primary consideration 2